180 related articles for article (PubMed ID: 30353857)
21. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.
Spitzer AL; Lao OB; Dick AA; Bakthavatsalam R; Halldorson JB; Yeh MM; Upton MP; Reyes JD; Perkins JD
Liver Transpl; 2010 Jul; 16(7):874-84. PubMed ID: 20583086
[TBL] [Abstract][Full Text] [Related]
22. Risk of extended criteria donors in hepatitis C virus-positive recipients.
Berenguer M
Liver Transpl; 2008 Oct; 14 Suppl 2():S45-50. PubMed ID: 18825715
[TBL] [Abstract][Full Text] [Related]
23. Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature.
Routh D; Naidu S; Sharma S; Ranjan P; Godara R
J Clin Exp Hepatol; 2013 Dec; 3(4):337-46. PubMed ID: 25755521
[TBL] [Abstract][Full Text] [Related]
24. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD
Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057
[TBL] [Abstract][Full Text] [Related]
25. Liver transplant outcomes using ideal donation after circulatory death livers are superior to using older donation after brain death donor livers.
Scalea JR; Redfield RR; Foley DP
Liver Transpl; 2016 Sep; 22(9):1197-204. PubMed ID: 27314220
[TBL] [Abstract][Full Text] [Related]
26. Contribution of marginal donors to liver transplantation for hepatitis C virus infection.
Briceño J; Ciria R; Pleguezuelo M; Naranjo A; Sánchez-Hidalgo J; Ruiz-Rabelo J; López-Cillero P; Luque A; de la Mata M; Rufián S
Transplant Proc; 2007 Sep; 39(7):2297-9. PubMed ID: 17889169
[TBL] [Abstract][Full Text] [Related]
27. [Renal transplantation].
Rostaing L
Nephrol Ther; 2017 Jun; 13(6S):6S25-6S29. PubMed ID: 29463396
[TBL] [Abstract][Full Text] [Related]
28. Role of basic studies in expanding the donor pool for liver transplantation.
Chen H; Zhang Y; Zhou L; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):571-80. PubMed ID: 19073401
[TBL] [Abstract][Full Text] [Related]
29. The utility of extended criteria donor organs in severely ill liver transplant recipients.
Mittler J; Pascher A; Neuhaus P; Pratschke J
Transplantation; 2008 Oct; 86(7):895-6. PubMed ID: 18852650
[TBL] [Abstract][Full Text] [Related]
30. Extended donors in liver transplantation.
Harring TR; O'Mahony CA; Goss JA
Clin Liver Dis; 2011 Nov; 15(4):879-900. PubMed ID: 22032534
[TBL] [Abstract][Full Text] [Related]
31. The role of an interdisciplinary transplant team on living donation kidney transplantation program.
Fonouni H; Golriz M; Mehrabi A; Oweira H; Schmied BM; Müller SA; Jarahian P; Tahmasbi Rad M; Esmaeilzadeh M; Tönshoff B; Weitz J; Büchler MW; Zeier M; Schmidt J
Transplant Proc; 2010; 42(1):137-40. PubMed ID: 20172299
[TBL] [Abstract][Full Text] [Related]
32. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival.
Frongillo F; Avolio AW; Nure E; Mulè A; Pepe G; Magalini SC; Agnes S
Transplant Proc; 2009 May; 41(4):1268-72. PubMed ID: 19460535
[TBL] [Abstract][Full Text] [Related]
33. Single-Center Experience Using Marginal Liver Grafts in Korea.
Park PJ; Yu YD; Yoon YI; Kim SR; Kim DS
Transplant Proc; 2018 May; 50(4):1147-1152. PubMed ID: 29731083
[TBL] [Abstract][Full Text] [Related]
34. The marginal donor: a single-center experience in orthotopic liver transplantation.
Scuderi V; Ceriello A; Maida P; Aragiusto G; Arenga G; Carfora T; Defez M; Giuliani A; Monti GN; Santaniello W; Sicoli F; Calise F
Transplant Proc; 2006 May; 38(4):1069-73. PubMed ID: 16757267
[TBL] [Abstract][Full Text] [Related]
35. Birmingham liver unit: use of marginal donors for liver transplantation.
Starkey G; Buckels J
Clin Transpl; 2008; ():137-42. PubMed ID: 19708452
[TBL] [Abstract][Full Text] [Related]
36. Liver transplantation in the United States, 1999-2008.
Thuluvath PJ; Guidinger MK; Fung JJ; Johnson LB; Rayhill SC; Pelletier SJ
Am J Transplant; 2010 Apr; 10(4 Pt 2):1003-19. PubMed ID: 20420649
[TBL] [Abstract][Full Text] [Related]
37. Donor pool expansion in liver transplantation.
Montalti R; Nardo B; Bertelli R; Beltempo P; Puviani L; Vivarelli M; Cavallari A
Transplant Proc; 2004 Apr; 36(3):520-2. PubMed ID: 15110578
[TBL] [Abstract][Full Text] [Related]
38. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
[TBL] [Abstract][Full Text] [Related]
39. Expanding the donor pool for liver transplantation with marginal donors.
Goldaracena N; Cullen JM; Kim DS; Ekser B; Halazun KJ
Int J Surg; 2020 Oct; 82S():30-35. PubMed ID: 32422385
[TBL] [Abstract][Full Text] [Related]
40. The use of old donors in liver transplantation.
Dasari BVM; Schlegel A; Mergental H; Perera MTPR
Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):211-217. PubMed ID: 28624109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
